Clinical research: Long-term studies track autism’s trajectory
Two studies published over the past month followed individuals with autism at various ages and showed that they gain developmental skills differently than controls do.
Two studies published over the past month followed individuals with autism at various ages and showed that they gain developmental skills differently than controls do.
A new initiative launched by the National Institute of Mental Health aims to redefine clinical trials for autism by funding short, biomarker-based studies that will allow investigators to quickly rule out ineffective compounds.
Toddlers with autism who receive behavioral interventions that improve joint attention — engaging and following others’ focus — have better language ability five years later than do controls, according to a study published in May in the Journal of the American Academy of Child and Adolescent Psychiatry.
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
Social impairments in autism are likely a consequence of deficits in social motivation that start early in life and have profound developmental consequences, says psychologist Robert Schultz.
Mutant mice with autism-like behaviors have fewer behavioral impairments when provided with toys, exercise wheels and contact with other mice, than do those that live in typical laboratory cages, according to a study published 5 April in Human Molecular Genetics.
Children who have both autism and intellectual disability may understand fewer words than their speaking skills suggest, which is not the case for typically developing children or those with intellectual disability alone. The results were published 21 February in the Journal of Autism and Developmental Disorders.
Children with autism are bullied three times more than their typically developing siblings, according to research from the Interactive Autism Network.
Early intensive intervention is the only therapy that has been shown to be effective in young children with autism, according to a 2011 review of autism treatments commissioned by the U.S. Agency for Healthcare Research and Quality. But researchers are just beginning to tease out what they refer to as its ‘active ingredients:’ why the treatment works, which elements are essential and why it fails to help some children.
How easy it is to engage the attention of a child with autism by gazing or pointing at an object may predict how well he or she will be able to function as an adult, according to a study published in the February issue of the Journal of Autism and Developmental Disorders.